Literature DB >> 4139225

Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.

A N Theofilopoulos, F J Dixon, V A Bokisch.   

Abstract

In the present work we studied the expression of membrane-bound Ig (MBIg) as well as receptors for IgG Fc and complement on nine human lymphoblastoid cell lines. When MBIg and receptors for IgG Fc were compared, four categories of cell lines could be distinguished: (a) cell lines having both MBIg and receptors for IgG Fc, (b) cell lines having MBIg but lacking receptors for IgG Fc, (c) cell lines lacking MBIg but having receptors for IgG Fc, and (d) cell lines lacking both MBIg and receptors for IgG Fc. Two types of receptors for complement could be detected on the cell lines studied, one for C3-C3b and one for C3d. When sensitized red cells carrying C3b or C3d were used for rosette tests, three categories of cell lines could be distinguished: (a) cell lines having receptors for C3b and C3d, (b) cell lines having receptors only for C3d and (c) cell lines lacking both receptors. However, when a more sensitive immunofluorescent method was used instead of the rosette technique, it was found that cell lines unable to form rosettes with EAC1423b(hu) were able to bind soluble C3 or C3b which indicated the presence of these receptors on the cell surface. Inhibition experiments showed that receptors for C3-C3b and receptors for C3d are distinct and that receptors for C3-C3b and C3d are different from receptors for IgG Fc. A cell line (Raji) without MBIg but with receptors for IgG Fc, C3-C3b, and C3d was selected for use in studying the binding mechanism of soluble immune complexes to cell surface membrane. Aggregated human gamma globulin was used in place of immune complexes. Immune complexes containing complement bind to Raji cells only via receptors for complement, namely receptors for C3-C3b and C3d. Binding of immune complexes containing complement to cells is much greater than that of complexes without complement. Immune complexes bound to cells via receptors for complement can be partially released from the cell surface by addition of normal human serum as well as isolated human C3 or C3b. We postulate that such release is due to competition of immune complex bound C3b and free C3 or C3b for the receptors on Raji cells.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4139225      PMCID: PMC2139634          DOI: 10.1084/jem.140.4.877

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Synthesis of immunoglobulins by human cell lines in tissue culture.

Authors:  I Finegold; J L Fahey; H Granger
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

3.  Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

Authors:  H Huber; M J Polley; W D Linscott; H H Fudenberg; H J Müller-Eberhard
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

4.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

5.  Human lymphoblastoid lines from lymph node and spleen.

Authors:  J A Levy; M Virolainen; V Defendi
Journal:  Cancer       Date:  1968-09       Impact factor: 6.860

6.  Products of lymphoid cells in continuous culture.

Authors:  P R Glade; K Hirschhorn
Journal:  Am J Pathol       Date:  1970-09       Impact factor: 4.307

7.  Deficiency of the sixth component of complement in rabbits with an inherited complement defect.

Authors:  K Rother; U Rother; H J Müller-Eberhard; J R Nilsson
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

8.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

9.  Deficiency of the fifth component of complement in mice with an inherited complement defect.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  37 in total

1.  A cat model for the evaluation of mechanisms of bone resorption: induction of bone loss by simulated immune complexes and inhibition by indomethacin.

Authors:  M Torbinejad; J Clagett; D Engel
Journal:  Calcif Tissue Int       Date:  1979       Impact factor: 4.333

2.  Enzyme immunoassay for detection of antibody to Epstein-Barr virus-specific early antigen.

Authors:  D J Garnlund; P H Levine; D A Fuccillo
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

Review 3.  The internal thioester and the covalent binding properties of the complement proteins C3 and C4.

Authors:  S K Law; A W Dodds
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

4.  C3-reacted sepharose: a preparative method for separating T and B lymphocytes.

Authors:  P Casali; B M Perussia
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

5.  Normal human serum restores the expression of Fc gamma receptors in immune complex-blocked human mononuclear cells.

Authors:  J R Geffner; G Serebrinsky; M A Isturiz
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

6.  Surface receptors on human haematopoietic cell lines.

Authors:  C Huber; C Sundström; K Nilsson; H Wigzell
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

7.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

8.  Immune complexes with antiglobulin activity in sera of Moloney sarcoma-bearing rats.

Authors:  J R Balint
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

9.  Significance of circulating HBs antigen-antibody immune complexes in patients with HBs antigen-positive liver disease.

Authors:  K Sugiura; Y Hasumura; J Takeuchi
Journal:  Gastroenterol Jpn       Date:  1982

10.  Alternative pathway-mediated rebinding of immune complexes to human red blood cells.

Authors:  M E Medof; G M Prince
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.